Literature DB >> 17387329

Channel, neuronal and clinical function in sodium channelopathies: from genotype to phenotype.

Stephen G Waxman1.   

Abstract

What is the relationship between sodium channel function, neuronal function and clinical status in channelopathies of the nervous system? Given the central role of sodium channels in the generation of neuronal activity, channelopathies involving sodium channels might be expected to cause either enhanced sodium channel function and neuronal hyperexcitability associated with positive clinical manifestations such as seizures, or attenuated channel function and neuronal hypoexcitability associated with negative clinical manifestations such as paralysis. In this article, I review observations showing that changes in neuronal function and clinical status associated with channelopathies are not necessarily predictable solely from the altered physiological properties of the mutated channel itself. I discuss evidence showing that cell background acts as a filter that can strongly influence the effects of ion channel mutations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17387329     DOI: 10.1038/nn1857

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  34 in total

Review 1.  Genetic disorders of ion channels.

Authors:  Decha Enkvetchakul
Journal:  Mo Med       Date:  2010 Jul-Aug

2.  Autism and Epilepsy: Exploring the Relationship Using Experimental Models.

Authors:  Carl E Stafstrom; Tim A Benke
Journal:  Epilepsy Curr       Date:  2015 Jul-Aug       Impact factor: 7.500

Review 3.  Channelopathies: summary of the hot topic keynotes session.

Authors:  Jason P Magby; April P Neal; William D Atchison; Isaac P Pessah; Timothy J Shafer
Journal:  Neurotoxicology       Date:  2011-07-02       Impact factor: 4.294

4.  Voltage-gated Na+ channels: potential for beta subunits as therapeutic targets.

Authors:  William J Brackenbury; Lori L Isom
Journal:  Expert Opin Ther Targets       Date:  2008-09       Impact factor: 6.902

5.  Inherited pain: sodium channel Nav1.7 A1632T mutation causes erythromelalgia due to a shift of fast inactivation.

Authors:  Mirjam Eberhardt; Julika Nakajima; Alexandra B Klinger; Cristian Neacsu; Kathrin Hühne; Andrias O O'Reilly; Andreas M Kist; Anne K Lampe; Kerstin Fischer; Jane Gibson; Carla Nau; Andreas Winterpacht; Angelika Lampert
Journal:  J Biol Chem       Date:  2013-12-05       Impact factor: 5.157

Review 6.  Sodium channel blockers for the treatment of neuropathic pain.

Authors:  Anindya Bhattacharya; Alan D Wickenden; Sandra R Chaplan
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

7.  Colonic inflammation up-regulates voltage-gated sodium channels in bladder sensory neurons via activation of peripheral transient potential vanilloid 1 receptors.

Authors:  Q Lei; A P Malykhina
Journal:  Neurogastroenterol Motil       Date:  2012-03-15       Impact factor: 3.598

8.  Effects of ranolazine on wild-type and mutant hNav1.7 channels and on DRG neuron excitability.

Authors:  Mark Estacion; Stephen G Waxman; Sulayman D Dib-Hajj
Journal:  Mol Pain       Date:  2010-06-08       Impact factor: 3.395

Review 9.  HSV vector-mediated modification of primary nociceptor afferents: an approach to inhibit chronic pain.

Authors:  J R Goss; M S Gold; J C Glorioso
Journal:  Gene Ther       Date:  2009-04       Impact factor: 5.250

10.  Calpain mediates proteolysis of the voltage-gated sodium channel alpha-subunit.

Authors:  Catherine R von Reyn; Jennifer M Spaethling; Mahlet N Mesfin; Marek Ma; Robert W Neumar; Douglas H Smith; Robert Siman; David F Meaney
Journal:  J Neurosci       Date:  2009-08-19       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.